Become a Media Partner
Our aim is to deliver the latest industry news to our attendees. If you a journalist, blogger or news agency in the field of business intelligence and would like to be represented throughout this summit we offer several options for branding to our media partners.
Contact us today:
CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
American Pharmaceutical Review
American Pharmaceutical Review is an informative and unbiased voice on industry trends, regulatory movements, technological advances, and scientific research reaching more than 30,000 senior executives, R&D and formulation scientists, bioprocessing and QA/QC specialists, and prominent pharmaceutical professionals. American Pharmaceutical Review highlights key movements in drug delivery, spectroscopy, bioprocessing, instrumentation, formulation development, microbiology and more.
Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensing.com) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.
IPI – International Pharmaceutical Industry
IPI – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.
Edited by our carefully selected editorial advisory panel, and extensive research network, IPI provides a proven supportive means of communication to the pharmaceutical, bio pharmaceutical, nutraceutical and medical devices industry the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies which will enable them to be more efficient, bring products to market faster, reduce cost and make healthcare accessible to all.
We have established a strong presence in the US, Central Europe, Middle East, Latin America, Eastern Europe, Asia and Africa which are becoming increasingly important to the way the industry is moving forward in areas of Research and Development, Trials, Manufacturing and Technology Transfer.
The Orphan Druganaut Blog
The Orphan Druganaut Blog provides real-time competitive intelligence, medical information services, news, articles, clinical trials, and Internet buzz on global orphan drug and rare disease developments
Founded in 2000, Technology Networks is now the leading provider of free information services for academics and industry professionals within the life science and drug discovery sectors. Our portfolio of 28 communities provides a base for members to access the latest news, events, products and research from their chosen field. All communities can be accessed through
pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.
Swiss Biotech Association
The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.
Rare Disease Communications
Rare Disease Communications raises awareness of orphan diseases by developing and disseminating relevant information to clinicians, patients, and advocates through our interactive platforms.
Medical News Today
Medical News Today is the largest independent medical and health news site on the web – with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact email@example.com or visit www.medicalnewstoday.com.
DutchCC focuses on organizing conferences, educational sessions, matchmaking events and trade missions to strengthen the positioning of the Dutch Biomedical and Life Sciences industry. Johan Hanstede is founder and director of DutchCC. Because of his active career in the biomedical industry, including 12 years of Business Development at Amgen, he has extensive, proven experience in organizing and leading large international events in the biomedical sector. Hanstede is also co-founder of the Dutch associations BioFarmind (biomedical industry) and the Dutch Vaccines Group (vaccine industry). Both associations are merged to HollandBIO in 2013.
HollandBIO is the Netherlands’ biotech industry organization. The Netherlands is home to a vibrant, dense biotechnology cluster of more than 1150 life science companies and research organizations, all operating within a 120-mile radius. HollandBIO connects, supports and represents many in this tight-knit community in order to promote economic growth, better health and greater sustainability.
Dedicated to paediatric and rare diseases, Rarebase provides bespoke consultancy and workshops, encourages networking and cooperation and connects different stakeholders across the market segments through the unique Networking Portal.
Personalize My Medicine (PMM) places people and patients at the center by informing them of the latest advances in medical innovation relevant to their condition. PMM researches, informs, and facilitates advancements in healthcare for anyone who wants to be more proactive about their own health by conducting surveys, setting up research networks, crowdfunding for medical innovation, and promoting medical innovation for orphan diseases. Please be invited to www.personalizemymedicine.com to find out more about what we do and how you can work with us.
Biocompare (www.biocompare.com) is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.
Pharmatching.com is an efficient, targeted and easy-to-use-“Web2.0”-tool for finding the right partners in the pharmaceutical industry worldwide. It saves time and costs in all (out)sourcing and business development processes, as it fascilitates and accelerates the searching process for appropriate business partners significantly.
Pharmatching.com is particularly advantageous for projects where a special service is (immediately) required or to offer capacities which are currently available. It is useful for services in all categories and stages of drug development including contract manufacturing, contract research, laboratory investigations, contractual testing, non-clinical and clinical research, active pharmaceutical ingredients, consulting, marketing, registration, in- and outlicensing etc.